B‐cell depletion in autoimmune hepatitis: Is it safe for the bowel?
Mostafa M. Sira, Ahmad M. Sira – 17 December 2015
MDR3 mutation analysis: A step closer to precision medicine
Jorge A. Bezerra – 17 December 2015
Nucleos(t)ide analogs reduce the risk of hepatitis B‐associated hepatocellular carcinoma: A can't miss proposition?
Neil Mehta, Francis Y. Yao – 17 December 2015
Theranostical nanosystem‐mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma
Yu Guo, Jing Wang, Lu Zhang, Shunli Shen, Ruomi Guo, Yang Yang, Wenjie Chen, Yiru Wang, Guihua Chen, Xintao Shuai – 17 December 2015 – Because the primary surgical treatment options for hepatocellular carcinoma (HCC)—including hepatic resection and liver transplantation—often fail due to recurrence and metastasis, identifying early prognostic biomarkers and therapeutic targets for HCC is of great importance.
Liver capsule: Cholangiocarcinoma (CCA)
Sumera Rizvi, Gregory J. Gores – 15 December 2015
Liver capsule: Cholangiocarcinoma (CCA)
Sumera Rizvi, Gregory J. Gores – 15 December 2015
Diabetes prevention through prevention of hepatitis B
James Lin, Horng‐Yih Ou, Lee‐Ming Chuang, Ken C. Chiu – 13 December 2015
Model for end‐stage liver disease limbo, model for end‐stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
Andres F. Carrion, Saira A. Khaderi, Norman L. Sussman – 13 December 2015
Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease
Philippe Gual, Catherine Postic – 13 December 2015
Hippocalcin‐like 1 suppresses hepatocellular carcinoma progression by promoting p21Waf/Cip1 stabilization by activating the ERK1/2‐MAPK pathway
Yonglong Zhang, Yanfeng Liu, Jinlin Duan, Haibo Yan, Jun Zhang, Huilu Zhang, Qi Fan, Feifei Luo, Guoquan Yan, Ke Qiao, Jie Liu – 13 December 2015 – Hepatocellular carcinoma (HCC) is the third leading cause of cancer‐related death. However, the underlying mechanism during hepatocarcinogenesis remains unclarified. Stable isotope labeling by amino acids in cell culture (SILAC) is a powerful quantitative strategy for proteome‐wide discovery of novel biomarkers in cancers. Hippocalcin‐like 1 (HPCAL1) is a calcium sensor protein.